Trends in anti-HER2 drugs consumption and influencing factors

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) inhibitors have been approved to treat various cancers with HER2 amplification. The Chinese government has made great efforts to improve the availability and affordability of these drugs. This study aimed to analyze the trends in anti-HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Zhang, Xiaolei, Wang, Biao, Dai, Huizhen, Dou, Dahai, Fang, Wentong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493110/
https://www.ncbi.nlm.nih.gov/pubmed/36159303
http://dx.doi.org/10.3389/fpubh.2022.944071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493110/
https://www.ncbi.nlm.nih.gov/pubmed/36159303
http://dx.doi.org/10.3389/fpubh.2022.944071

Ejemplares similares